Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
JAMA Surgery
|
December 3, 2015
Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma
Christina L Roland, Genevieve M Boland, Elizabeth G Demicco, et al.
BMC Cancer
|
November 18, 2015
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
Caitlin D May, Jeannine Garnett, XiaoYan Ma, et al.
Head & Neck
|
April 16, 2016
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes
Indu Varier, Brieze R Keeley, Rosemarie Krupar, et al.
Cell Reports. Medicine
|
August 15, 2023
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Joshua M Wang, Runyu Hong, Elizabeth G Demicco, et al.
Cancer Cell
|
August 15, 2023
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Wen-Wei Liang, Rita Jui-Hsien Lu, Reyka G Jayasinghe, et al.
Cell Genomics
|
April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Iga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 13, 2026
VGLL3-rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases with Consistently Indolent Behavior
Esther Baranov, Baptiste Ameline, Ruth Berthold, et al.
The American Journal of Surgical Pathology
|
October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease
Claudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
Immunity
|
April 10, 2018
The Immune Landscape of Cancer
Vésteinn Thorsson, David L Gibbs, Scott D Brown, et al.
Cancer Treatment Reviews
|
August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
JAMA Surgery
|
December 3, 2015
Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma
Christina L Roland, Genevieve M Boland, Elizabeth G Demicco, et al.
BMC Cancer
|
November 18, 2015
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
Caitlin D May, Jeannine Garnett, XiaoYan Ma, et al.
Head & Neck
|
April 16, 2016
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes
Indu Varier, Brieze R Keeley, Rosemarie Krupar, et al.
Cell Reports. Medicine
|
August 15, 2023
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Joshua M Wang, Runyu Hong, Elizabeth G Demicco, et al.
Cancer Cell
|
August 15, 2023
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Wen-Wei Liang, Rita Jui-Hsien Lu, Reyka G Jayasinghe, et al.
Cell Genomics
|
April 18, 2025
Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets
Iga Kołodziejczak-Guglas, Renan L S Simões, Emerson de Souza Santos, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 13, 2026
VGLL3-rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases with Consistently Indolent Behavior
Esther Baranov, Baptiste Ameline, Ruth Berthold, et al.
The American Journal of Surgical Pathology
|
October 28, 2024
International Multicenter Retrospective Study From the Ultra-rare Sarcoma Working Group on Low-grade Fibromyxoid Sarcoma, Sclerosing Epithelioid Fibrosarcoma, and Hybrid Forms: Outcome of Primary Localized Disease
Claudia Giani, Abdulazeez Salawu, Silva Ljevar, et al.
Immunity
|
April 10, 2018
The Immune Landscape of Cancer
Vésteinn Thorsson, David L Gibbs, Scott D Brown, et al.
Cancer Treatment Reviews
|
August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Page
of 11